HOME >> BIOLOGY >> NEWS
Photosystem I -- An Intermediate Step -- May Not Be Necessary For Plants

ITHACA, N.Y. -- Plant biologists have long held the view that photosynthesis -- the process by which cells in green plants convert the energy of sunlight into chemical energy and use carbon dioxide to produce sugars -- needs two intermediate light-dependent reactions for successful energy conversion: Photosystem II and Photosystem I.

But according to a new study reported today (July 19), that dogma may have gone for a walk, and scientists may have to rethink some aspects of how photosynthesis works. "Scientists have thought they understood photosynthesis for a long time, and this revelation flies in the face of what we know," said Thomas G. Owens, Cornell University associate professor of plant biology. "What does this all mean? No one knows yet."

The Z scheme is the classic example of how scientists describe the light-dependent reactions of photosynthesis. When photons -- particles of light -- enter a plant cell, their energy is used to power two sequential light-dependent reactions. In Photosystem II (PSII), the light energy is used to split water, producing oxygen and electrons. In Photosystem I (PSI), these electrons are used to produce compounds that ultimately react with carbon dioxide to produce carbohydrates, lipids, proteins and nucleic acids -- the fundamental components of life.

But Owens and researchers from the Oak Ridge National Laboratory in Tennessee found that in some cases photosynthesis can occur in the absence of PSI, they report in the journal Science (July 19, 1996). The report, "Oxygenic Photoautotrophic Growth Without Photosystem I," was authored by James W. Lee, C.V. Tevault and Elias Greenbaum, all of the Oak Ridge National Laboratory, and Cornell's Owens.

The scientists from Oak Ridge used artificially developed mutants of a green alga to find this new life process.

"It is a very important discovery; I didn't believe any of this stuff when it was first reported. I thought it was impossible, but cooperation between
'"/>

Contact: Blaine Friedlander
bpf2@cornell.edu
607-255-3290
Cornell University News Service
19-Jul-1996


Page: 1 2

Related biology news :

1. Oxygen-Carrying Myoglobin Not Necessary For Survival
2. Plants will not save us from greenhouse gases
3. Plants for the future: A European vision for plant biotechnology towards 2025
4. Plants circadian clocks tune into latitude to enhance fitness
5. Plants and people share a molecular signaling system, researchers discover
6. Nonnative Invasive Plants of Southern Forests
7. Plants, insects play cat and mouse game
8. Plants vs. disease: Trench warfare at the molecular level
9. Plants as plants: gene could convert crops to plastics factories
10. Plants, pathogens engage in trench warfare
11. Study: Microgravity May Enhance Gene Transfer In Plants

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Photosystem Intermediate Step May Not Necessary For Plants

(Date:2/23/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announced today ... DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND SYSTEM. ... payment method. Payment accounts may be selected via voice ... if both the speech (the word associated with the ...
(Date:2/18/2015)... Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... speaking at the following conferences, and invited investors to participate ... Boston, MA Tuesday, March 3, 2015 ... Investors Conference, Orlando, FL Wednesday, March ... Live Webcasts To access the live webcasts for these events, ...
(Date:2/12/2015)... Feb. 12, 2015   MedNet Solutions , ... clinical study management systems, has recently bolstered its ... distinguishing iMedNet as the ... (CROs) and healthcare consultants.  Building on the Program,s ... referrals and numerous co-marketing opportunities), MedNet,s new and ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3Cepheid to Webcast Upcoming Financial Presentations 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
(Date:2/27/2015)... SUNNYVALE, Calif. , Feb. 27, 2015 /PRNewswire/ ... announced that longer-term toxicology studies for its newly ... arthritis, or RA, have been completed. The results ... the U.S. Food and Drug Administration. The feedback ... completion of the ongoing first-in-human study. Additional preclinical ...
(Date:2/27/2015)... 2015 The fully automated supercritical ... can sequentially analyze up to 48 samples utilizing ... detection of targets by mass spectrometry. , ... the measurement requirements of a wide range of ... delivery and search for disease biomarkers, additives in ...
(Date:2/27/2015)... Cytokinetics, Incorporated (Nasdaq: CYTK) announced today ... patients and health care advocates in the United States ... Rare Disease Day is dedicated to elevating public ... special challenges faced by patients with rare diseases and ... to stand alongside patients and caregivers representing the rare ...
(Date:2/26/2015)... WOODBRIDGE, N.J. , Feb. 26, 2015 ... and its affiliated companies, Wilentz, Goldman & ... a trade secrets lawsuit against Genewiz Inc. in excess ... obtained and utilized GenScript,s trade secrets, and that it ... court entered an order denying motions for judgment notwithstanding ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
Cached News: